Samatha Antes

Remibrutinib Yields Rapid, Sustained Relief in Urticaria

March 8, 2025

TOPLINE:Remibrutinib, an oral Bruton’s tyrosine kinase inhibitor, reduced itch and hives in patients with chronic spontaneous urticaria and showed a...

Samatha Antes

Remibrutinib Yields Rapid, Sustained Relief in Urticaria

European Commission approves ustekinumab for paediatric Crohn’s disease

Elekta and Azra AI partner to advance cancer registry operations with AI

Organoid model integrates microglia to study inflammation in brain

Even the richest Americans face shorter lifespans than their European counterparts, study finds

‘Smart,’ ultrasound-activated immune cells may soon provide long-lasting tumor destruction

Air pollution drives lung cancer surge in non-smokers, study reveals

The link between renal failure and Parkinson’s disease: Researchers illuminate the underlying mechanisms

Algiax announces results from phase 2a trial for neuropathic pain treatment

Grifols collaborates with startup FcR Therapeutics to develop autoimmune therapies

A pharmacist’s guide to taking medications safely

European Commission approves ustekinumab for paediatric Crohn’s disease

Elekta and Azra AI partner to advance cancer registry operations with AI

Organoid model integrates microglia to study inflammation in brain

Even the richest Americans face shorter lifespans than their European counterparts, study finds

‘Smart,’ ultrasound-activated immune cells may soon provide long-lasting tumor destruction

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories